Aristotle Bamias

31PUBLICATIONS
141CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 12, 2026
Real-World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON-3 Study.

|Sep 22, 2026
Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group.

|Aug 27, 2026
Development and Broad Application of a Double Drop-Off ddPCR Assay for Simultaneous Detection of Four FGFR3 Mutations in Tissue and Liquid Biopsy Samples.

|May 04, 2026
KIM-1 as a Biomarker in Genitourinary Neoplasms.

|Feb 27, 2026
Circulating ERVFRD-1 and MFSD2A Are Associated with Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma.

Hector Katifelis, Styliani-Evangelia Zerva, Aristotelis Bamias

|Jan 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

Matthew D Galsky, Mark Kockx, Juliette Roels

Pageof 6

Frequent Collaborators

6 joint publications

Roubini Zakopoulou

6 joint publications

Meletios-Athanasios Dimopoulos

4 joint publications

Michalis Liontos

2 joint publications

Sotirios G Papageorgiou